Advocate Group’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
AACR
Advocate Group's JNJ Position: Q2 2026 in Review
Advocate Group reduced its Johnson & Johnson (JNJ) stake by 5.3% in Q2 2026, selling an estimated $795K and leaving 61,412 shares worth $15.6M. The position accounts for 2.34% of the portfolio, ranked #6.
Advocate Group first reported a position in JNJ in Q2 2022 and has held it in 17 quarters since. The position peaked at $15.8M in Q1 2026. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Advocate Group held 61,412 shares of Johnson & Johnson worth $15.6M as of Q2 2026.
- Advocate Group sold 3,413 Johnson & Johnson shares in Q2 2026, an estimated $795K.
- Johnson & Johnson made up 2.34% of Advocate Group's portfolio in Q2 2026, its #6 holding.
- Advocate Group first reported a position in Johnson & Johnson in Q2 2022 and has held it in 17 quarters since.
- Advocate Group's Johnson & Johnson position peaked at $15.8M in Q1 2026.
- 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Advocate Group's 13F filing for Q2 2026, filed 17 Jul 2026.